Clinical Trial: A First-in-Human Study of PRD001

U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07034183) titled 'A First-in-Human Study of PRD001' on March 27.

Brief Summary: The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of PRD001 in healthy participants and to evaluate the safety, tolerability, pharmacodynamics and pharmacokinetics of PRD001 in participants with borderline/mild hyper-LDL-cholesterolemia and mild fatty liver.

Study Start Date: June 19

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: PRD001

PRD001 capsules will be provided for oral administration

DRUG: Placebo

Placebo capsules will be provided for oral administration

Recruitment Status: RECRUITING

S...